News
News
- Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020
02/13/2020 / 22:01 - GlobeNewswire - Galecto Appoints Industry Leader Bertil Lindmark, MD, PhD, as Chief Medical Officer
02/03/2020 / 10:00 - GlobeNewswire - Paratek Awarded BARDA Project BioShield Contract for NUZYRA®
12/18/2019 / 23:12 - GlobeNewswire - Athenex Expands its Strategic Partnership with Guangzhou Xiangxue Pharmaceutical Through a Licensing Agreement for its Product Candidates Oral Paclitaxel and Oral Irinotecan, as well as Tirbanibulin Ointment, in China, Hong Kong and Macao
12/16/2019 / 13:00 - GlobeNewswire - ASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSs
12/06/2019 / 00:22 - GlobeNewswire - ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares
12/03/2019 / 07:00 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12/02/2019 / 22:05 - GlobeNewswire - Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
12/02/2019 / 18:50 - GlobeNewswire - ASLAN Pharmaceuticals Reports Positive Preliminary Data From Proof-of-Concept Study for ASLAN004 Targeting Atopic Dermatitis
12/02/2019 / 08:07 - GlobeNewswire - ASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica Journal
11/22/2019 / 07:30 - GlobeNewswire
Real-time